COVID-19: two years of challenges, lessons, victories

Two years ago this week, the cataclysmic coronavirus known as SARS-CoV-2 arrived in Middle Tennessee.

Vanderbilt and CDC research shows third vaccine dose key to preventing omicron hospitalization

Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.

Omicron evades some but not all monoclonal antibodies: study

A new study found that several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the Omicron variant now sweeping across the United States.

Weigh risks, plan ahead prior to gathering for the holidays

Vanderbilt University Medical Center infectious disease experts advise this is the season to think very wisely about planned get-togethers.

Pediatricians seeing increase in children with MIS-C after latest COVID surge

Rounds: Hard conversations